Resolute Onyx DES offers exceptional deliverability and enhanced visibility2 for complex chronic total occlusion (CTO) cases.
When it comes to treating small vessels, Resolute Onyx DES offers the lowest crossing profile for superior deliverability‡2 and is engineered to expand from 2.0 mm to 3.50 mm.§4
Lower Is Better
Average Force (gF)
Our smallest DES expands from 2.0–3.50 mm
and features low foreshortening when
expanded to 3.50 mm.§4,5
Resolute Onyx DES is designed for extra-large vessels and was the first DES to offer 4.50 and 5.00 mm sizes, which can now expand up to 6.00 mm.§4 It sustains structural strength and coating integrity when overexpanded and its 5 Fr compatibility is designed with the transradial approach in mind.2
Resolute Onyx DES Strut Thickness
Resolute Onyx DES Crowns
Higher Is Better||
In recent Medtronic studies, diabetes patients make up over 35% of the coronary stents implanted.1,6
View our latest product and therapy innovations, clinical evidence, and educational offerings for the interventional cardiology space.View the latest from Medtronic
Third-party brands are trademarks of their respective owners.
Endpoints presented from the PERSPECTIVE study (NCT02884206) were not powered.
Testing performed on smallest diameters available for Abbott Xience Alpine™*, Biotronik Orsiro™*, Boston Scientific Promus Premier™*, Boston Scientific Synergy™*, Medtronic Resolute Integrity™, and Medtronic Resolute Onyx coronary stents.
The Resolute Onyx stents should not be expanded to a diameter beyond the maximum labeled diameter listed per the IFU. Post-dilatation required for overexpansion.
Values shown in N/mm/mm. Testing measures the resistance to radial deformation.
Kandzari DE, Kirtane AJ, Windecker S, et al. One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients. Circ Cardiovasc Interv. November 2020;13(11):e009565.
Based on bench test data on file at Medtronic. May not be indicative of clinical performance.
Kandzari DE, Lembo NJ, Carlson HD, et al. Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study. Catheter Cardiovasc Interv. September 1, 2020;96(3):567-576.
Resolute Onyx DES, Instructions for Use.
Medtronic data on file.
Windecker S, Latib A, Kedhi E, et al. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. N Engl J Med. March 26, 2020;382(13):1208-1218.